PT - JOURNAL ARTICLE AU - Barbu, MC AU - Campbell, A AU - Amador, C AU - Adams, MJ AU - Lynall, ME AU - Howard, DM AU - Walker, RM AU - Bretherick, AD AU - Morris, SW AU - Porteous, DJ AU - Evans, KL AU - Haley, C AU - Bullmore, E AU - Whalley, HC AU - McIntosh, AM TI - Epigenome-wide association study of self-reported antidepressant use in Generation Scotland implicates the innate immune system AID - 10.1101/2020.10.06.20207621 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.06.20207621 4099 - http://medrxiv.org/content/early/2020/10/06/2020.10.06.20207621.short 4100 - http://medrxiv.org/content/early/2020/10/06/2020.10.06.20207621.full AB - Background Antidepressants are an effective treatment for major depressive disorder (MDD), although individual response is unpredictable and highly variable. Whilst the mode of action of antidepressants is incompletely understood, many medications are associated with changes in DNA methylation that are plausibly linked to their mechanisms. Studies of DNA methylation may therefore reveal the biological processes underpinning the efficacy and side effects of antidepressants.Methods We performed an epigenome-wide association study (EWAS) of self-reported antidepressant use accounting for lifestyle factors and MDD in the Generation Scotland cohort (N=6,428).Results We found 10 CpG sites significantly associated with self-reported antidepressant use, with the top CpG located within a gene previously associated with mental health disorders, ATP6V1B2 (β=-0.055, pcorrected=0.005). Other top loci, annotated to genes including CASP10, TMBIM1, MAPKAPK3, and HEBP2, have previously been implicated in the innate immune response. We also identified a number of disease-associated single nucleotide polymorphisms as trans and cis methylation quantitative trait loci (mQTLs) for CpG sites identified here. Next, using penalised regression, we trained a methylation-based score (MS) of self-reported antidepressant use in 3,799 individuals that predicted antidepressant use in a second subset of Generation Scotland (N=3,360,β=0.377, p=3.12×10−11,R2=2.12%). Lastly, in an EWAS analysis of SSRI antidepressant prescribing data from electronic health records, we showed convergent findings with those based on self-report.Conclusions Antidepressants may exert their effects through epigenetic alterations in regions previously associated with mental health disorders and those involved in the innate immune system. These changes predicted self-reported antidepressant use in a subset of Generation Scotland and identify processes that may be relevant to our mechanistic understanding of clinically relevant antidepressant drug actions and side effects.Competing Interest StatementADB would like to acknowledge funding from the Wellcome PhD training fellowship for clinicians (204979/Z/16/Z), the Edinburgh Clinical Academic Track (ECAT) programme. EB is an NIHR Senior Investigator and is a member of the scientific advisory board of Sosei Heptares. ML is supported by a fellowship from the Medical Research Council (MR/S006257/1). DMH is supported by a Sir Henry Wellcome Postdoctoral Fellowship (Reference 213674/Z/18/Z) and a 2018 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (Ref: 27404).Funding StatementADB would like to acknowledge funding from the Wellcome PhD training fellowship for clinicians (204979/Z/16/Z), the Edinburgh Clinical Academic Track (ECAT) programme. EB is an NIHR Senior Investigator and is a member of the scientific advisory board of Sosei Heptares. ML is supported by a fellowship from the Medical Research Council (MR/S006257/1). DMH is supported by a Sir Henry Wellcome Postdoctoral Fellowship (Reference 213674/Z/18/Z) and a 2018 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (Ref: 27404).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:GS:SFHS received ethical approval from NHS Tayside Research Ethics Committee (REC reference number 05/S1401/89) and has Research Tissue Bank Status (reference: 15/ES/0040). Written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request, contacting individuals here: https://www.ed.ac.uk/generation-scotland